Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 35 | 2024 | 7265 | 3.230 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 19 | 2023 | 1542 | 3.050 |
Why?
|
Apoptosis | 42 | 2023 | 7757 | 2.180 |
Why?
|
Apoptosis Regulatory Proteins | 9 | 2022 | 622 | 1.770 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 11 | 2013 | 123 | 1.750 |
Why?
|
Inhibitor of Apoptosis Proteins | 9 | 2014 | 202 | 1.520 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 11 | 2021 | 2635 | 1.480 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 7 | 2024 | 1013 | 1.470 |
Why?
|
Fusion Proteins, bcr-abl | 9 | 2020 | 1144 | 1.380 |
Why?
|
Blast Crisis | 8 | 2021 | 588 | 1.330 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 7 | 2023 | 288 | 1.320 |
Why?
|
Sulfonamides | 8 | 2024 | 1933 | 1.190 |
Why?
|
Phenanthrenes | 5 | 2020 | 43 | 1.190 |
Why?
|
Antineoplastic Agents | 23 | 2023 | 14617 | 1.180 |
Why?
|
Diterpenes | 5 | 2020 | 115 | 1.150 |
Why?
|
Interleukin-1beta | 2 | 2019 | 294 | 1.050 |
Why?
|
Mitochondrial Proteins | 5 | 2019 | 379 | 1.030 |
Why?
|
fms-Like Tyrosine Kinase 3 | 7 | 2023 | 838 | 1.030 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2022 | 5408 | 1.010 |
Why?
|
Cytoskeletal Proteins | 2 | 2019 | 522 | 0.980 |
Why?
|
Microtubule-Associated Proteins | 6 | 2007 | 530 | 0.910 |
Why?
|
Tumor Suppressor Protein p53 | 11 | 2024 | 3658 | 0.900 |
Why?
|
Caspases | 6 | 2016 | 679 | 0.900 |
Why?
|
Gene Expression Regulation, Leukemic | 8 | 2021 | 586 | 0.850 |
Why?
|
Cell Line, Tumor | 30 | 2023 | 14849 | 0.800 |
Why?
|
Biomimetic Materials | 1 | 2022 | 39 | 0.800 |
Why?
|
Protein Kinase Inhibitors | 11 | 2022 | 4961 | 0.790 |
Why?
|
Neoplastic Stem Cells | 6 | 2020 | 1456 | 0.780 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 6 | 2023 | 525 | 0.710 |
Why?
|
Nerve Tissue Proteins | 2 | 2019 | 1581 | 0.690 |
Why?
|
Piperazines | 8 | 2015 | 2145 | 0.680 |
Why?
|
Leukemia, Myeloid | 6 | 2019 | 993 | 0.680 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2020 | 116 | 0.680 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 1281 | 0.670 |
Why?
|
Muscle Proteins | 2 | 2014 | 551 | 0.640 |
Why?
|
Antigens, CD34 | 4 | 2016 | 640 | 0.610 |
Why?
|
Tumor Microenvironment | 3 | 2019 | 3035 | 0.600 |
Why?
|
Dinoprostone | 1 | 2019 | 219 | 0.600 |
Why?
|
Cell Proliferation | 13 | 2021 | 7238 | 0.590 |
Why?
|
Mice | 22 | 2023 | 35600 | 0.570 |
Why?
|
Antimetabolites, Antineoplastic | 5 | 2019 | 1347 | 0.570 |
Why?
|
Dipeptides | 2 | 2014 | 96 | 0.570 |
Why?
|
Leukemia | 6 | 2024 | 1719 | 0.560 |
Why?
|
Antineoplastic Agents, Alkylating | 3 | 2009 | 605 | 0.550 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 495 | 0.540 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 885 | 0.530 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2017 | 163 | 0.530 |
Why?
|
Drug Synergism | 8 | 2021 | 1356 | 0.530 |
Why?
|
Proto-Oncogene Proteins | 2 | 2024 | 2617 | 0.520 |
Why?
|
Wnt Signaling Pathway | 2 | 2020 | 444 | 0.520 |
Why?
|
beta Catenin | 2 | 2020 | 683 | 0.520 |
Why?
|
Animals | 30 | 2023 | 61956 | 0.520 |
Why?
|
Caspase 8 | 2 | 2014 | 146 | 0.510 |
Why?
|
Pyrimidines | 7 | 2015 | 3669 | 0.500 |
Why?
|
Imatinib Mesylate | 8 | 2020 | 1691 | 0.490 |
Why?
|
Cell Survival | 9 | 2018 | 3063 | 0.490 |
Why?
|
Tumor Cells, Cultured | 7 | 2020 | 5759 | 0.470 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2020 | 3917 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 9042 | 0.460 |
Why?
|
Oligonucleotides | 3 | 2013 | 242 | 0.460 |
Why?
|
Mice, SCID | 5 | 2020 | 1826 | 0.420 |
Why?
|
bcl-2-Associated X Protein | 2 | 2023 | 374 | 0.400 |
Why?
|
NF-kappa B | 2 | 2016 | 1563 | 0.400 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 896 | 0.400 |
Why?
|
Indoles | 2 | 2014 | 1028 | 0.390 |
Why?
|
Benzamides | 8 | 2021 | 1879 | 0.380 |
Why?
|
Humans | 64 | 2024 | 270740 | 0.380 |
Why?
|
Cytarabine | 5 | 2015 | 2014 | 0.370 |
Why?
|
Down-Regulation | 3 | 2016 | 2090 | 0.360 |
Why?
|
Neoplasm Proteins | 7 | 2010 | 3345 | 0.360 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 593 | 0.350 |
Why?
|
Mutation | 7 | 2024 | 15912 | 0.350 |
Why?
|
Idarubicin | 2 | 2011 | 459 | 0.330 |
Why?
|
Aminopyridines | 2 | 2021 | 223 | 0.320 |
Why?
|
Cell Cycle | 5 | 2018 | 2137 | 0.320 |
Why?
|
Oligonucleotides, Antisense | 5 | 2013 | 255 | 0.310 |
Why?
|
Myelodysplastic Syndromes | 3 | 2024 | 3156 | 0.300 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 2 | 2010 | 210 | 0.300 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 16689 | 0.300 |
Why?
|
Epoxy Compounds | 5 | 2020 | 57 | 0.300 |
Why?
|
Mitochondria | 5 | 2023 | 1297 | 0.300 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 63 | 0.300 |
Why?
|
Stem Cells | 3 | 2023 | 1216 | 0.300 |
Why?
|
Masoprocol | 1 | 2007 | 18 | 0.290 |
Why?
|
CDC2 Protein Kinase | 2 | 2007 | 188 | 0.290 |
Why?
|
Signal Transduction | 9 | 2017 | 12103 | 0.280 |
Why?
|
Aniline Compounds | 2 | 2008 | 206 | 0.280 |
Why?
|
Cell Death | 3 | 2023 | 685 | 0.280 |
Why?
|
HL-60 Cells | 5 | 2015 | 318 | 0.270 |
Why?
|
Blotting, Western | 5 | 2014 | 3584 | 0.270 |
Why?
|
Proteins | 2 | 2005 | 2043 | 0.260 |
Why?
|
Hematopoietic Stem Cells | 1 | 2012 | 1367 | 0.250 |
Why?
|
Disease Models, Animal | 6 | 2023 | 7381 | 0.230 |
Why?
|
Antioxidants | 1 | 2007 | 521 | 0.230 |
Why?
|
Cell Adhesion | 2 | 2017 | 1028 | 0.220 |
Why?
|
ADP-ribosyl Cyclase 1 | 2 | 2015 | 149 | 0.220 |
Why?
|
DNA Methylation | 1 | 2014 | 2765 | 0.220 |
Why?
|
Caspase Inhibitors | 1 | 2003 | 95 | 0.220 |
Why?
|
PPAR alpha | 1 | 2023 | 61 | 0.220 |
Why?
|
Heterografts | 2 | 2023 | 738 | 0.210 |
Why?
|
Gene Knockdown Techniques | 3 | 2017 | 1076 | 0.210 |
Why?
|
Lipid Peroxidation | 1 | 2023 | 164 | 0.200 |
Why?
|
Phospholipids | 1 | 2023 | 167 | 0.200 |
Why?
|
c-Mer Tyrosine Kinase | 1 | 2022 | 28 | 0.200 |
Why?
|
Dasatinib | 2 | 2024 | 881 | 0.190 |
Why?
|
Phenylurea Compounds | 1 | 2005 | 600 | 0.190 |
Why?
|
Imidazoles | 3 | 2015 | 1065 | 0.190 |
Why?
|
Protein Array Analysis | 2 | 2014 | 503 | 0.180 |
Why?
|
Stromal Cells | 2 | 2017 | 825 | 0.170 |
Why?
|
Membrane Glycoproteins | 2 | 2015 | 1094 | 0.160 |
Why?
|
Peptidomimetics | 1 | 2019 | 28 | 0.160 |
Why?
|
U937 Cells | 3 | 2008 | 178 | 0.160 |
Why?
|
Oxytocics | 1 | 2019 | 33 | 0.160 |
Why?
|
Male | 16 | 2024 | 128315 | 0.160 |
Why?
|
Biomarkers, Tumor | 4 | 2020 | 10708 | 0.150 |
Why?
|
Azacitidine | 2 | 2015 | 1218 | 0.150 |
Why?
|
Female | 18 | 2024 | 148940 | 0.150 |
Why?
|
Middle Aged | 13 | 2024 | 90352 | 0.150 |
Why?
|
Gene Duplication | 1 | 2019 | 442 | 0.150 |
Why?
|
Myeloproliferative Disorders | 2 | 2024 | 882 | 0.140 |
Why?
|
Molecular Targeted Therapy | 3 | 2019 | 2399 | 0.140 |
Why?
|
Coculture Techniques | 2 | 2020 | 628 | 0.140 |
Why?
|
bcl-X Protein | 2 | 2015 | 198 | 0.140 |
Why?
|
Thiones | 1 | 2016 | 19 | 0.140 |
Why?
|
Acute Disease | 5 | 2010 | 2493 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2023 | 1710 | 0.140 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 3597 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 617 | 0.130 |
Why?
|
Gene Expression | 2 | 2017 | 3640 | 0.130 |
Why?
|
Aged | 9 | 2024 | 73333 | 0.130 |
Why?
|
MicroRNAs | 2 | 2021 | 2887 | 0.130 |
Why?
|
Protein Transport | 1 | 2018 | 737 | 0.130 |
Why?
|
Glycoside Hydrolases | 2 | 1992 | 42 | 0.130 |
Why?
|
Nitrophenols | 1 | 2015 | 95 | 0.120 |
Why?
|
Gene Silencing | 1 | 2018 | 827 | 0.120 |
Why?
|
Auranofin | 1 | 2014 | 36 | 0.120 |
Why?
|
Nuclear Proteins | 2 | 2023 | 3438 | 0.120 |
Why?
|
Biphenyl Compounds | 1 | 2015 | 188 | 0.120 |
Why?
|
Cell Communication | 1 | 2017 | 512 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2015 | 1810 | 0.110 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 2013 | 14 | 0.110 |
Why?
|
Adult | 10 | 2024 | 82040 | 0.110 |
Why?
|
Leupeptins | 1 | 2013 | 71 | 0.110 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2013 | 138 | 0.110 |
Why?
|
Primary Myelofibrosis | 1 | 2021 | 914 | 0.110 |
Why?
|
Oligochaeta | 1 | 1992 | 1 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2011 | 6390 | 0.100 |
Why?
|
I-kappa B Proteins | 1 | 2013 | 177 | 0.100 |
Why?
|
Survival Analysis | 3 | 2017 | 9292 | 0.100 |
Why?
|
Thiazoles | 2 | 2021 | 723 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2010 | 1838 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2006 | 382 | 0.100 |
Why?
|
Drug Design | 1 | 2014 | 372 | 0.100 |
Why?
|
Transplantation, Heterologous | 3 | 2014 | 1054 | 0.100 |
Why?
|
Antirheumatic Agents | 1 | 2014 | 230 | 0.100 |
Why?
|
Boronic Acids | 1 | 2013 | 354 | 0.090 |
Why?
|
Bortezomib | 1 | 2013 | 549 | 0.090 |
Why?
|
Myeloid Progenitor Cells | 1 | 2011 | 48 | 0.090 |
Why?
|
Oligopeptides | 1 | 2013 | 450 | 0.090 |
Why?
|
Drug Dosage Calculations | 1 | 2011 | 45 | 0.090 |
Why?
|
Pyrazines | 1 | 2013 | 510 | 0.090 |
Why?
|
Caspase 6 | 1 | 2009 | 15 | 0.090 |
Why?
|
RNA Interference | 1 | 2014 | 1388 | 0.090 |
Why?
|
Aged, 80 and over | 3 | 2017 | 30998 | 0.080 |
Why?
|
Pyridines | 1 | 2016 | 1313 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 875 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 1584 | 0.080 |
Why?
|
Mice, Nude | 4 | 2020 | 4329 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2016 | 4223 | 0.080 |
Why?
|
Cell Movement | 1 | 2016 | 2472 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 2196 | 0.080 |
Why?
|
Young Adult | 4 | 2024 | 22251 | 0.080 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2008 | 92 | 0.070 |
Why?
|
Glioblastoma | 1 | 2017 | 1776 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 694 | 0.070 |
Why?
|
Jurkat Cells | 1 | 2007 | 319 | 0.070 |
Why?
|
Retinoids | 1 | 2006 | 149 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2010 | 959 | 0.070 |
Why?
|
Antigens, CD | 1 | 2011 | 1418 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 661 | 0.060 |
Why?
|
Caspase 9 | 1 | 2006 | 187 | 0.060 |
Why?
|
Adolescent | 4 | 2020 | 32767 | 0.060 |
Why?
|
Biomarkers | 1 | 2017 | 5051 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 561 | 0.060 |
Why?
|
Iron | 2 | 2023 | 380 | 0.060 |
Why?
|
Recurrence | 2 | 2011 | 4878 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 5149 | 0.060 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2006 | 191 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 3530 | 0.060 |
Why?
|
Autophagy | 1 | 2010 | 911 | 0.060 |
Why?
|
DNA, Antisense | 1 | 2003 | 44 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2006 | 669 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 4960 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2006 | 639 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2010 | 4328 | 0.050 |
Why?
|
Prognosis | 3 | 2019 | 22505 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 2454 | 0.050 |
Why?
|
Genes, p53 | 1 | 2006 | 1140 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2023 | 262 | 0.050 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2023 | 317 | 0.050 |
Why?
|
Smoothened Receptor | 1 | 2021 | 53 | 0.050 |
Why?
|
Glutathione | 1 | 2023 | 374 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2009 | 2098 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 7044 | 0.050 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 57 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2006 | 1309 | 0.050 |
Why?
|
Polycomb Repressive Complex 1 | 1 | 2021 | 85 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2017 | 4958 | 0.050 |
Why?
|
Genetic Therapy | 1 | 2008 | 1716 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2022 | 469 | 0.040 |
Why?
|
Lipids | 1 | 2023 | 654 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2008 | 1435 | 0.040 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 264 | 0.040 |
Why?
|
Leukemia, Myeloid, Chronic-Phase | 1 | 2024 | 531 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2003 | 968 | 0.040 |
Why?
|
Cell Division | 1 | 2003 | 2657 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 1942 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2020 | 271 | 0.040 |
Why?
|
Genetic Loci | 1 | 2021 | 501 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 1553 | 0.040 |
Why?
|
Disease Progression | 2 | 2021 | 6867 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2019 | 5056 | 0.040 |
Why?
|
Nickel | 1 | 2016 | 45 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 15927 | 0.030 |
Why?
|
Reactive Oxygen Species | 2 | 2014 | 1005 | 0.030 |
Why?
|
Aclarubicin | 1 | 2015 | 2 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 198 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2006 | 4116 | 0.030 |
Why?
|
Proteasome Inhibitors | 1 | 2016 | 235 | 0.030 |
Why?
|
Harringtonines | 1 | 2015 | 93 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2003 | 5694 | 0.030 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2014 | 9 | 0.030 |
Why?
|
Proteomics | 1 | 2022 | 1427 | 0.030 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4795 | 0.030 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2014 | 225 | 0.030 |
Why?
|
Alleles | 1 | 2019 | 2600 | 0.030 |
Why?
|
G(M1) Ganglioside | 1 | 1992 | 11 | 0.030 |
Why?
|
Chromatography, Thin Layer | 1 | 1992 | 69 | 0.030 |
Why?
|
Glycosphingolipids | 1 | 1992 | 21 | 0.030 |
Why?
|
Dogs | 1 | 2014 | 1160 | 0.030 |
Why?
|
Hydrolysis | 1 | 1992 | 237 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 1441 | 0.030 |
Why?
|
Genes, fos | 1 | 1991 | 55 | 0.020 |
Why?
|
Transferases | 1 | 1991 | 9 | 0.020 |
Why?
|
Glycoconjugates | 1 | 1991 | 15 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 575 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1992 | 600 | 0.020 |
Why?
|
Autophagy-Related Protein 12 | 1 | 2010 | 5 | 0.020 |
Why?
|
Child | 2 | 2024 | 30559 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 1992 | 354 | 0.020 |
Why?
|
Oligosaccharides | 1 | 1991 | 113 | 0.020 |
Why?
|
Beclin-1 | 1 | 2010 | 88 | 0.020 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 49 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 5593 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 5776 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2471 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1991 | 425 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2019 | 33737 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2010 | 94 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 5437 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 2156 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2016 | 3339 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1991 | 1028 | 0.020 |
Why?
|
Caspase 3 | 1 | 2008 | 474 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2016 | 6177 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 1991 | 1017 | 0.020 |
Why?
|
K562 Cells | 1 | 2006 | 344 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2009 | 401 | 0.020 |
Why?
|
Flavonoids | 1 | 2006 | 199 | 0.020 |
Why?
|
Receptors, Retinoic Acid | 1 | 2006 | 367 | 0.020 |
Why?
|
Purines | 1 | 2006 | 271 | 0.020 |
Why?
|
Rats | 1 | 2014 | 6441 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2008 | 804 | 0.010 |
Why?
|
Lysine | 1 | 2006 | 426 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 1958 | 0.010 |
Why?
|
Glycine | 1 | 2006 | 322 | 0.010 |
Why?
|
Hydroxamic Acids | 1 | 2006 | 454 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 768 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2015 | 10265 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 2069 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 1525 | 0.010 |
Why?
|
Adenoviridae | 1 | 2008 | 1497 | 0.010 |
Why?
|
Benzopyrans | 1 | 2002 | 41 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1991 | 4130 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2010 | 2928 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 1569 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 10400 | 0.010 |
Why?
|
Nitriles | 1 | 2002 | 939 | 0.010 |
Why?
|
Leeches | 1 | 1991 | 3 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 1991 | 722 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1991 | 606 | 0.000 |
Why?
|